Stable Giants: 3 Bigwig Biotech Stocks For Consistent Returns
Biotech stocks have had a rough post-pandemic. In a year where the S&P500 is up more than 10% year to date, the biotech sector is still negative to flat. But biotech stocks will bounce back. Some biotech stocks will remain very volatile, especially small biotechs relying on clinical trials. However, the broader sector is still poised for consistent growth. As our population ages…








